the pharmaceutical company Bayer AG marketed acetylsalicylic acid under the trade name Aspirin, but taking ‘aspirin’ for a ...

As Bayer AG shares head for their worst week in almost a year, the days of 2015 when the German company was valued at more ...

Swiss generic and biosimilar medicines major Sandoz today announced that the European Commission (EC) has granted marketing ...

Afqlir is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) ...

BASEL, Switzerland I November 15, 2024 I Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced that the ...

U.S. farmers struggling with slumping incomes and depressed grain prices have been switching to cheaper generic pesticides ...

Bayer AG (BAYRY) reports strong performance in Pharmaceuticals and Consumer Health, while facing headwinds in Crop Science ...

U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

Bayer's Nubeqa achieves blockbuster status, marking significant growth in cancer treatment, while Xarelto maintains its ...

The pharmaceutical-and-agricultural group lowered its profit target for 2024 after tough market conditions hit its ...

Brand recognition is key in this unit, as evidenced by the company's iconic Aspirin, which continues to post strong sales even after decades of generic competition. In addition to healthcare, Bayer ...